ArticleJournal of visualized experiments : JoVE2026
A Ferric Ammonium Citrate-Based Model of Iron Overload With Ferroptosis-Associated Readouts In C2C12 Myoblasts.
Article in Journal of visualized experiments : JoVE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ferroptosis is an iron-dependent form of regulated cell death implicated in aging and degenerative disease. We previously found that aged muscle stem cells accumulate intracellular iron and undergo ferroptotic death upon activation. Here, we describe a simple in vitro model that uses ferric ammonium citrate to generate iron overload in murine C2C12 myoblasts. Ferric ammonium citrate treatment increased intracellular iron burden, as shown by elevated ferritin heavy- and light-chain transcripts, increased ferritin protein, and enhanced signal from a live-cell labile iron dye. Ferric ammonium citrate (FAC) exposure also produced molecular changes associated with ferroptosis, including increased Slc40a1 and Hmox1 expression and reduced glutathione peroxidase 4 protein. The FAC-associated decrease in glutathione peroxidase 4 was partially reversed by deferoxamine. At 12 hours, cytotoxic ferric ammonium citrate reduced cell viability, and this effect was rescued by ferrostatin-1, consistent with a ferroptosis-sensitive component of cell death. At later time points, increased variability and reduced assay dynamic range limit the interpretability of viability measurements. Thus, this protocol provides a rapid and scalable model of ferric ammonium citrate-mediated iron loading that can be used to study ferroptosis-associated responses and test iron- or ferroptosis-modifying interventions in muscle cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.